| Patent application number | Description | Published |
|---|
| 20080206329 | Modified Release Ciprofloxacin Compositions - Controlled release tablets comprising ciprofloxacin, with hardness and friability of the said tablets ranges between 10 to 70 kiloponds and less than 2% respectively, the compositions releasing at least 80 percent of the total amount of the ciprofloxacin into a pH 1.2 aqueous dissolution medium within about 1 hour. | 08-28-2008 |
| 20080260785 | PAROXETINE COMPOSITIONS - The invention relates to pharmaceutical compositions having polymers that release paroxetine in a controlled manner for a prolonged or sustained period of time. An embodiment of the invention provides enhanced bioavailability controlled release pharmaceutical compositions comprising paroxetine or its pharmaceutically acceptable salts, which enables a reduction in its orally administered dose. | 10-23-2008 |
| 20090012146 | SOLUBILITY-ENHANCED PHARMACEUTICAL COMPOSITIONS COMPRISING ZAFIRLUKAST - Stable pharmaceutical compositions comprising zafirlukast and pharmaceutically acceptable salts, solvates, polymorphs, enantiomers or mixtures thereof, together with one or more pharmaceutically acceptable polymers, and processes for their preparation. | 01-08-2009 |
| 20090028944 | PHARMACEUTICAL COMPOSITIONS COMPRISING MESALAMINE - Pharmaceutical compositions comprising mesalamine, wherein the compositions are free of a liphophilic matrix, and processes for preparing pharmaceutical compositions comprising mesalamine and being free of a liphophilic matrix. | 01-29-2009 |
| 20090124657 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONTELUKAST - Pharmaceutical compositions comprising montelukast or pharmaceutically acceptable salts, solvates, polymorphs, enantiomers or mixtures thereof. | 05-14-2009 |
| 20090252787 | GRANULAR PHARMACEUTICAL COMPOSITIONS - Pharmaceutical compositions comprising a plurality of formulated particles containing at least one active ingredient and at least one pharmaceutically acceptable excipient, granulated with a granulating composition containing at least one pharmaceutical excipient. | 10-08-2009 |
| 20090324728 | PHARMACEUTICAL COMPOSITIONS COMPRISING AMORPHOUS BENZIMIDAZOLE COMPOUNDS - Compositions comprising amorphous substituted benzimidazole compounds. | 12-31-2009 |
| 20100029743 | ATORVASTATIN PHARMACEUTICAL COMPOSITIONS - The present invention relates to pharmaceutical formulations of atorvastatin or its pharmaceutically acceptable salts, solvates, hydrates, enantiomers, polymorphs or their mixtures; and processes for preparing the same, and their methods of use, treatment and administration. Further, the present invention relates to pharmaceutical compositions comprising an acid-solubility-enhanced form of atorvastatin or its salts. | 02-04-2010 |
| 20100068269 | TREATMENT AND PREVENTION OF CARDIOVASCULAR EVENTS - A pharmaceutical dosage form for treating or preventing cardiovascular events comprises therapeutic amounts of: a β-adrenergic receptor antagonist, a diuretic, or both; a cholesterol-lowering agent; an inhibitor of the renin-angiotensin system; and aspirin. | 03-18-2010 |
| 20100129310 | STABILIZED DESLORATADINE COMPOSITION - Stabilized desloratadine-containing pharmaceutical compositions are prepared using complexes formed by combining desloratadine and a resin in the acidic form. | 05-27-2010 |
| 20100183710 | OMEPRAZOLE FORM B - A process for preparing pure omeprazole Form B, and compositions containing omeprazole Form B. | 07-22-2010 |
